November 14 from 7:00 am – 8:30 am EST
If left uncontrolled, spondyloarthritis can cause progressive structural joint damage and irreversible disability. Early identification and treatment initiation is crucial for successful outcomes. In this symposium expert faculty will discuss the rationale for long-term disease control and how to improve standards of care based on shared decision making and patient characteristics and preferences. Recommendations on how to select treatments will be discussed in light of the latest clinical evidence.
This activity is intended for rheumatologists, dermatologists, and primary care physicians (PCPs).
Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Supported by an independent educational grant from UCB Pharma, Inc.
JOIN US IN PHILADELPHIA MARRIOTT DOWNTOWN | GRAND BALLROOM E
Iain B. McInnes CBE, PhD, FRCP, FRSE, FMedSci
University of Glasgow
Professor of Medicin
Joseph F. Merola MD, MMSc
Harvard Medical School
Lianne S. Gensler MD
University of California
Professor of Medicine
San Francisco, California
This is not an official program of the American College of Rheumatology